Alexandro Bonifaz
Alexandro Bonifaz is an expert in Infectiology at Hospital General de México (Mexico). As of September 2026, ScienceLeadR ranks Alexandro Bonifaz in the top 1% of experts worldwide for Mycoses and Skin Diseases, Infectious. Alexandro Bonifaz has authored 319 publications, the most recent in 2026. SLR score: 933 (community average: 125). How the SLR is computed.
LeadR Profile
Infectiology
Subspecialties: Dermatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 1993 - 2026
Number : 319
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Potential clinical implications due to essential differences in antimicrobial susceptibility profiles of actinomycetoma causative agents of the Actinomadura, Nocardia and Streptomyces genera towards commonly used anti-actinomycetoma drugs. PMID 42788689 — genes, actinobacteria, pharmaceutical preparations, amoxicillin, nocardia, drug therapy, rifampin, actinomadura, streptomyces | J Antimicrob Chemother | 2026 | 0 |
| Fungal diagnostics and antifungal drug access in Latin America and the Caribbean: an ESCMID EFISG multinational survey. PMID 42521684 — biological science disciplines, pharmaceutical preparations, income, drug monitoring, mycoses, amphotericin b, therapeutics | Nat Commun | 2026 | 1 |
| Establishment of epidemiological cutoff values against Fonsecaea monophora, an agent of chromoblastomycosis and cerebral phaeohyphomycosis. PMID 42345564 — fonsecaea, abscess, research design, mortality, voriconazole, terbinafine, itraconazole, brain, central nervous system infections, flucytosine, microbiology, central nervous system, chromoblastomycosis, cerebral phaeohyphomycosis, fungi, amphotericin b, therapeutics, nervous system, brain abscess, infections, phaeohyphomycosis | J Clin Microbiol | 2026 | 2 |
| Reply to Chen et al., "Methodological considerations for the establishment of epidemiological cutoff values for Sporothrix species using CLSI broth microdilution". PMID 42340338 — sporothrix, drug therapy, anti-bacterial agents, antiviral agents | Antimicrob Agents Chemother | 2026 | 0 |
| Sporotrichosis in Patients with Diabetes Mellitus: A Systematic Review of Individual Participant Data. PMID 42261088 — diabetes mellitus, sporothrix, mycoses, amphotericin b, therapeutics, sporotrichosis | Med Mycol | 2026 | 0 |
LeadR Networks
Main global connection map